We are pleased to announce the fifth Cold Spring Harbor Virtual meeting on Mechanisms of Metabolic Signaling & Disease which will begin on Tuesday morning, October 26 and end on Friday, October 29, 2021.
Metabolic signaling is at the intersection of many scientific fields, ranging from basic biochemistry and molecular biology to physiology and pathophysiology. Currently, a major challenge for these disparate fields is to define commonalities and differences in the function and regulation of metabolism, and determine the role of metabolic signals in normal physiology as well as disease states. This meeting will fill an important gap by bringing together outstanding researchers with a common goal of understanding the role and regulation of metabolic signals in a diverse array of pathways, cell types, and diseases.
Day | Time (ET) | Session # | Session Name |
Tuesday |
9:30 am - 12:30 pm |
1 |
Metabolism and Cell Proliferation |
Tuesday |
1:00 pm - 2:00 pm |
|
Poster Session* |
Tuesday |
2:30 pm - 5:30 pm |
2 |
Emerging Technologies |
Wednesday |
9:30 am - 12:30 pm |
3 |
Keynote Session and Workshop |
Wednesday |
1:00 pm - 2:00 pm |
|
Poster Session* |
Wednesday |
2:30 pm - 5:30 pm |
4 |
Nutrient Utilization |
Thursday |
9:30 am - 12:30 pm |
5 |
Metabolic Crosstalk with Genome and Epigenome |
Thursday |
1:00 pm - 2:00 pm |
|
Poster Session* |
Thursday |
2:30 pm - 5:30 pm |
6 |
Metabolism in Specialized Cell Types |
Friday |
9:30 am - 12:30 pm |
7 |
Inter-organ Crosstalk |
Friday |
1:00 pm - 2:00 pm |
|
Poster Session* |
Friday |
2:30 pm - 5:30 pm |
8 |
Metabolite Signaling |
Virtual Icebreaker |
6:00 pm |
|
Tuesday, 6:00 pm |
Discussion Zone |
|
|
30-minutes following each oral session (open Zoom format) |
|
|
|
|
*Virtual Poster Session will be available for viewing throughout the meeting
On-demand recordings of the daily Zoom sessions will be made available for 24 hours starting the following day, followed by longer-term access to the Leading Strand archive the week after the meeting.
Daily Schedule
City | "Morning" Oral Session | Poster Session | "Afternoon" Oral Session |
Los Angeles |
6:30 am - 9:30 am |
10:00 am - 11:00 am |
11:30 am - 2:30 pm |
New York |
9:30 am - 12:30 pm |
1:00 pm - 2:00 pm |
2:30 pm - 5:30 pm |
London |
2:30 pm - 5:30 pm |
6:00 pm - 7:00 pm |
7:30 pm - 10:30 pm |
Berlin |
3:30 pm - 6:30 pm |
7:00 pm - 8:00 pm |
8:30 pm - 11:30 pm |
Tokyo |
10:30 pm - 1:30 am |
2:00 am - 3:00 am |
3:30 am - 6:30 am |
Keynote Speakers:
Aviv Regev, Genentech
Karen Vousden, Francis Crick Institute, UK
Discussion Leaders:
Theodore Alexandrov, EMBL Heidelberg, Germany
Zoltan Arany, University of Pennsylvania, Perelman School of Medicine
Kivanc Birsoy, The Rockefeller University
Anne Brunet, Stanford University
Navdeep Chandel, Northwestern University Feinberg School of Medicine
Ana Domingos, University of Oxford, UK
Ayelet Erez, Weizmann Institute of Science, Israel
Mark Febbraio, Monash University, Australia
Sarah-Maria Fendt, VIB-KU Leuven Center for Cancer Biology, Belgium
Lydia Finley, Memorial Sloan Kettering Cancer Center
Anna Gloyn, Stanford University
David Guertin, University of Massachusetts Medical School
Adam Hughes, University of Utah
Ullas Kolthur, Tata Institute of Fundamental Research, India
W. Lee Kraus, UT Southwestern Medical Center
Andreas Ladurner, Biomedical Center, Ludwig-Maximillians University of Munich, Germany
Christian Metallo, Salk Institute for Biological Studies
Raymond Moellering, University of Chicago
Erika Pearce, Johns Hopkins University School of Medicine
Randy Seeley, University of Michigan
Ira Tabas, Columbia University
Benjamin Tu, UT Southwestern Medical Center
Matthew Vander Heiden, Massachusetts Institute of Technology
Aimin Xu, The University of Hong Kong, Hong Kong
Yingming Zhao, University of Chicago
The format of the meeting will include eight oral sessions and two poster sessions. Each oral session will include invited speakers and speakers selected from submitted abstracts. For this reason, abstracts from both junior and senior investigators are warmly invited. The abstracts should focus on new and unpublished data. The organizers will select abstracts for oral or poster presentations.
We are eager to have as many young people as possible attend, and we have applied for funds from government and industry to partially support graduate students and postdocs. All questions pertaining to registration, fees, housing, meals, transportation, visas, abstract submission, financial aid, or any other matters should be directed to Val Pakaluk.
Social Media:
The designated hashtag for this meeting is #cshlmetab. Note that you must obtain permission from an individual presenter before live-tweeting or discussing his/her talk, poster, or research results on social media. Click the Policies tab above to see our full Confidentiality & Reporting Policy.
Partial support provided by: National Institute of Diabetes and Digestive and Kidney Diseases
Late Pricing: (registrations submitted after 5:00 p.m. ET on October 21, 2021)
Late Virtual Academic Package: $395
Late Virtual Graduate Student Package: $280
Late Virtual Corporate Package: $535
Rules for Virtual Participation: Virtual participation will include access to the oral sessions via Zoom, access to the digital poster sessions and access to the Slack discussion channel, and the Leading Strand video archive.
Presenters: Individuals submitting abstracts and facing financial barriers should firstly request financial aid (see above). Permission to present your talk or poster virtually will be given only in exceptional circumstances and on a case-by-case basis. If you think you are eligible for an exemption from the requirement to present in person, please provide a justification in writing via email to Val Pakaluk.
Non-presenting participants: We plan to broaden access to the conference by allowing certain categories of non-presenting participants to attend at reduced fees. Categories include:
1. Additional members of individual laboratories (4th or more lab member) - PI must supply list of lab members via email to Val Pakaluk.
2. Individuals from low & middle income countries;
3. Individuals from non-LMIC countries in Asia, Australasia, Africa or South America;
4. Individuals from US & Canadian minority serving institutions;
5. Individuals with a demonstrable financial barrier;
6. Individuals with family obligations or other special circumstances.
For categories 5 & 6 above, please provide a justification via email to Val Pakaluk.